Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
25 Jul 2008 - 25 Aug 2008
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Ministry of Labor Ordinance No. 76, 1988 and Ordinance No.13, 2000
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
methyl 2-[(prop-2-en-1-yloxy)methyl]prop-2-enoate
EC Number:
819-688-6
Cas Number:
219828-90-7
Molecular formula:
C8H12O3
IUPAC Name:
methyl 2-[(prop-2-en-1-yloxy)methyl]prop-2-enoate
Test material form:
liquid

Method

Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
not specified
Species / strain / cell type:
E. coli WP2 uvr A
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
Dose-finding study:
Test substance groups: Selected in accordance with the “Guidelines”.
Positive control groups: Selected in accordance with the concentrations for positive control substances in “Guide to Mutagenicity Studies under the Industrial Safety and Health Act”
Concentrations: 0.00305, 0.0122, 0.00488, 0.195, 0781, 3.13, 12.5 and 50 mg/mL.

Main study:
In the dose-finding study, growth inhibitions were observed at 5000μg/plate for five tester strains in the absence and presence of the metabolic activity system. Therefore, the composition of groups in the main study included 6 dose levels by a common ratio of 2 both in the absence and presence of the metabolic activity system; from the highest dose of 5000 μg/plate to the lowest dose of 156 μg/plate.
Concentrations: 1.56, 3.13, 6.25, 12.5 and 50 mg/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test substance is insoluble in water, but soluble at 50 mg/mL or more in DMSO. Therefore, DMSO was selected as the solvent.
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
N-ethyl-N-nitro-N-nitrosoguanidine
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION:
Additive volume of the prepared solution 100 μL per plate. Reason for the additive volume of the prepared solution 100 µL, which is the maximal possible volume without inhibition of bacterial growth by DMSO, was selected for positive control substances. Also, the same volume was selected for the test substance and negative control solutions.

45 μL of each tester strain were directly inoculated into 20 mL of 2.5% nutrient broth. The resulting mixture was cultured with shaking at 50 rpm for 9 hr at 37°C.
After incubation, the optical density of bacterial suspensions was measured to confirm that the viable bacterial count was not less than 1.0 × 10E9/mL.

In the absence of the metabolic activation system (without S9 mix):
500 μL of 100 mM Na-phosphate buffer (pH 7.4) and 100 μL of bacterial suspension were added to 100 μL of the test solution in each culture tube and the suspending solution was pre-incubated with shaking for 20 minutes at 37°C. Subsequently, 2 mL of a mixture of 0.5 mM biotin-0.5 mM histidine solution (in case of E. coli: 0.5 mM tryptophan solution) and 0.6% soft agar fluid (volume ratio 1:10) was added to each of the suspending solutions, and then poured onto the minimal glucose agar plate (Tesmedia AN Medium, Oriental Yeast Co., Ltd.,). All the plates were incubated for 48 hours at 37°C.
In the presence of metabolic activation system (With S9 mix):
500 µL of S9 mix and 100 µL of bacterial suspension were added to 100 µL of the test solution in each culture tube and the suspending solution was pre-incubated with shaking for 20 minutes at 37°C. Subsequently, 2 mL of a mixture of 0.5 mM biotin-0.5 mM histidine solution (in case of E. coli: 0.5 mM tryptophan solution) and 0.6% soft agar fluid (volume ratio 1:10) was added to each of the suspending solutions, and then poured onto the minimal glucose agar plate. All the plates were incubated for 48 hours at 37°C.

After incubation, the presence or absence of precipitation was checked visually for all dose levels. Moreover, the background lawn was observed using a microscope to confirm the presence or absence of bacterial growth inhibition. Thereafter, the numbers of revertant colonies were counted, twice for each plate, using a colony counter (PC-10NII, Toyo Sokki Co., Ltd.). The number of colonies was corrected and the mean of the corrected values was the number of revertant colonies for each plate.
Rationale for test conditions:
Guidelines
Evaluation criteria:
Acceptance criteria
From the number of revertant colonies on each plate, the mean values (rounded to integers) are obtained. If all of the following criteria are met, the results are considered positive.
1) The number of revertant colonies in the test substance group is equal to or greater than twice the mean negative control value.
2) Dose-dependency is observed.
3) Reproducibility is observed when comparing the dose-finding study and main study results.
Statistics:
not specified

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
For five tester strains, the number of revertant colonies in the test substance groups did not increase greater than twice that in the negative control group in the absence or presence of the metabolic activation system.
Bacterial growth inhibition was observed at 2500 µg/plate and more for five tester strains in the absence and presence of the metabolic activation system.
Precipitation of the test substance on the plates was not observed in five tester strains in the absence or presence of the metabolic activation system.

Applicant's summary and conclusion

Conclusions:
In the results of the dose-finding study and main study, Methyl α-(Allyloxymethyl)acrylate did not induce increases in the number of revertant colonies for five tester strains in the absence or presence of the metabolic activation system, and the number did not reach more than twice that of the negative control group.
Therefore, Methyl α-(Allyloxymethyl)acrylate was judged not to be mutagenic agent, under the conditions of this study.